VT News
Bon Scott

Bon Scott

Ask VT AI
View News Summary
  • FDA rejects Capricor's cell therapy for Duchenne cardiomyopathy, citing insufficient evidence, but the company plans to resubmit with new trial data.
  • Levi Strauss lifts outlook, warns on future tariffs, showcasing resilience and adaptability in navigating trade challenges.
  • Amid escalating diplomatic tensions, Russia and Poland engage in a tit-for-tat closure of consulates, further straining their relations over the Ukraine conflict.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • FDA rejects Capricor's cell therapy for Duchenne cardiomyopathy, citing insufficient evidence, but the company plans to resubmit with new trial data.
  • Levi Strauss lifts outlook, warns on future tariffs, showcasing resilience and adaptability in navigating trade challenges.
  • Amid escalating diplomatic tensions, Russia and Poland engage in a tit-for-tat closure of consulates, further straining their relations over the Ukraine conflict.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Bon Scott

Top Topics

Trending in U.S.

World

Sport